When A Discovery Is Made, Pharmaceutical Companies Step In Building on this early work, Novo Nordisk developed, patented and secured FDA approval for two GLP-1 drugs to treat Type 2 diabetes: liraglutide and, a few years later, semaglutide
A person may feel better, eat more consistently, or improve protein intake while the scale temporarily stays flat
The genetic test does not predict whether semaglutide will work for you or how much weight you will lose
Most providers require a BMI of 30+ for weight loss alone, or 27+ with a co-morbidity like prediabetes, high blood pressure, sleep apnea, or fatty liver
The best time is whatever time works for your schedule and produces the fewest side effects for you personally
Every client responds differently, but many individuals notice changes in appetite and eating habits within the first several weeks of treatment